Evaluation
*
1=Very Poor, 5=Excellent
Very PoorPoorNeutralGoodExcellent
Overall Evaluation
Content
Usefulness
Quality
*
1=Strongly Disagree, 5= Strongly Agree
12345
Identify clinical classifications and disease progressive biomarkers in metastatic, and triple negative breast cancer
Analyze clinical trial data and mechanisms of action of available and developing therapeutics for metastatic breast cancer, as well as risk-benefit considerations in therapeutic selection
Implement disease monitoring and patient screening strategies to develop personalized treatment plans to optimize patient outcomes in advanced metastatic breast cancer
*
*
(1=Not confident at all, 2=Somewhat confident, 3=Confident, 4=Very confident, 5=Extremely confident, N/A=Not within the scope of my practice)
12345N/A
develop personalized treatment plans for patients with breast cancer
recognize and identify specific biomarkers in metastatic and triple negative breast cancer
*
*
*
1=Never, 2=Not often, 3=Sometimes, 4=Often, 5=Always, N/A=Not applicable to me
12345N/A
Identify clinical classifications and biomarkers when assessing subtypes of breast cancer
Utilize patient screening strategies in order to manage patients effectively
Apply current clinical trial data to appropriately manage patients with breast cancer